| 注册
首页|期刊导航|中国药理学通报|以IAPs为靶点的抗肿瘤研究进展

以IAPs为靶点的抗肿瘤研究进展

黄莹莹 刘浩

中国药理学通报2016,Vol.32Issue(5):612-615,4.
中国药理学通报2016,Vol.32Issue(5):612-615,4.DOI:10.3969/j.issn.1001-1978.2016.05.005

以IAPs为靶点的抗肿瘤研究进展

Anti-tumor research targeting IAPs

黄莹莹 1刘浩2

作者信息

  • 1. 蚌埠医学院第一附属医院药剂科
  • 2. 蚌埠医学院药学系,安徽 蚌埠 233000
  • 折叠

摘要

Abstract

Apoptosis inhibitors ( inhibitor of apoptosis proteins, IAPs) are a class of highly conserved apoptotic endogenous anti-cytokine family, primarily by inhibiting caspase activity and par-ticipation in regulation of nuclear factor NF-κB inhibition of ap-optosis. caspases cascade of protease activation is a central part of the apoptotic process, Bcl-2 family proteins and IAPs family proteins are the main controlling factors. In recent years, we found that abnormal expression of some IAPs members is closely associated with the tumor, a potential target for cancer therapy. Therefore, this paper reviews the major protein associated with IAPs family and anti-tumor research targeting IAPs.

关键词

肿瘤/凋亡/凋亡抑制因子/半胱氨酸蛋白酶/线粒体促凋亡蛋白/核因子

Key words

tumour/apoptosis/IAPs/caspases/Smac/NF-κB

分类

医药卫生

引用本文复制引用

黄莹莹,刘浩..以IAPs为靶点的抗肿瘤研究进展[J].中国药理学通报,2016,32(5):612-615,4.

基金项目

国家自然科学基金资助项目(No 81000992,81072207) (No 81000992,81072207)

安徽省高校自然科学研究项目( No KJ2015B070by) ( No KJ2015B070by)

蚌埠医学院自然科学基金资助项目(No byky1451) (No byky1451)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文